Chugai Pharmaceutical revenue
Chugai Pharmaceutical (4519) reported revenue of $7.87 B for fiscal year 2025, +7.46% compared with the year before. Over the last 12 months revenue was $8.85 B.
Revenue 2025$7.87 B
Change+7.46%
World rank#277
Market cap$74.85 B
Revenue by year
By year
| Year | Value | Change |
|---|---|---|
| 2025 | $7.87 B | +7.46% |
| 2024 | $7.33 B | +5.33% |
| 2023 | $6.96 B | −11.8% |
| 2022 | $7.89 B | — |
Converted to US dollars at today’s exchange rate. Data: company filings via Yahoo Finance, updated 2026-11-19. Not investment advice.